Frontiers in Oncology | Hematologic Malignancies

Correction

Published on 04 Oct 2023

Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

in Hematologic Malignancies

Adrián Mosquera Orgueira
Andrés Peleteiro Raíndo
José Ángel Díaz Arias
Beatriz Antelo Rodríguez
Mónica López Riñón
Claudio Cerchione
Adolfo de la Fuente Burguera
Marta Sonia González Pérez
Giovanni Martinelli
Pau Montesinos Fernández

Frontiers in Oncology

doi 10.3389/fonc.2023.1302993

1,250 views

Review

Published on 04 Oct 2023

Location, location, location: mapping the lymphoma tumor microenvironment using spatial transcriptomics

in Hematologic Malignancies

Keir Pickard
Emily Stephenson
Alex Mitchell
Laura Jardine
Chris M. Bacon

Frontiers in Oncology

doi 10.3389/fonc.2023.1258245

8,170 views
6 citations

Editorial

Published on 04 Oct 2023

Editorial: Biological aspects of bone marrow failure

in Hematologic Malignancies

Panagiotis Diamantopoulos
Serine Avagyan
Elena Solomou

Frontiers in Oncology

doi 10.3389/fonc.2023.1295823

1,694 views

Mini Review

Published on 04 Oct 2023

Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience

in Hematologic Malignancies

Hui-Lin Chin
Joyce Ching Mei Lam
Dheepa Christopher
Poon Limei Michelle
Benedict Yan Junrong

Frontiers in Oncology

doi 10.3389/fonc.2023.1182639

3,526 views
3 citations

Original Research

Published on 03 Oct 2023

Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma

in Hematologic Malignancies

Christos Panayi
Ayse U. Akarca
Alan D. Ramsay
Ananth G. Shankar
Brunangelo Falini
Miguel A. Piris
David Linch
Teresa Marafioti

Frontiers in Oncology

doi 10.3389/fonc.2023.1267604

3,753 views
6 citations

Original Research

Published on 03 Oct 2023

Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era

in Hematologic Malignancies

Reena Nair
Gull Mohammad Bhat
Narendra Agrawal
Manju Sengar
Pankaj Malhotra
Soniya Nityanand
Chitra Lele
Pramod Reddy
Suresh Kankanwadi
Narendra Maharaj

Frontiers in Oncology

doi 10.3389/fonc.2023.1248723

4,184 views
2 citations

Mini Review

Published on 02 Oct 2023

The interplay of FLT3 and CXCR4 in acute myeloid leukemia: an ongoing debate

in Hematologic Malignancies

Laura Klement
Julia Drube

Frontiers in Oncology

doi 10.3389/fonc.2023.1258679

3,536 views
4 citations

Case Report

Published on 02 Oct 2023

Case Report: A recurrent case of ALK-ALCL after autologous transplantation was successfully treated with BV + a modified CHEP chemotherapy containing mitoxantrone hydrochloride liposome with the addition of chidamide maintenance therapy

in Hematologic Malignancies

Zhen Shang
Qi Zhang
Wanying Liu
Jiaying Wu
Yicheng Zhang
Yi Xiao

Frontiers in Oncology

doi 10.3389/fonc.2023.1242552

3,366 views

Review

Published on 02 Oct 2023

Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling

in Hematologic Malignancies

Rahul Banerjee
Kara I. Cicero
Sarah S. Lee
Andrew J. Cowan

Frontiers in Oncology

doi 10.3389/fonc.2023.1240966

7,280 views
27 citations

Mini Review

Published on 29 Sep 2023

Biological insights into the role of TET2 in T cell lymphomas

in Hematologic Malignancies

Shannon A. Carty

Frontiers in Oncology

doi 10.3389/fonc.2023.1199108

5,267 views
3 citations

Case Report

Published on 29 Sep 2023

Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report

in Hematologic Malignancies

Petruta Gurban
Cristina Mambet
Anca Botezatu
Laura G. Necula
Ana I. Neagu
Lilia Matei
Ioana M. Pitica
Saviana Nedeianu
Mihaela Chivu-Economescu
Coralia Bleotu

Frontiers in Oncology

doi 10.3389/fonc.2023.1266996

3,751 views
2 citations

Original Research

Published on 27 Sep 2023

High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation

in Hematologic Malignancies

Damian Mikulski
Mateusz Nowicki
Izabela Dróźdż
Małgorzata Misiewicz
Kacper Piotr Kościelny
Karol Okoński
Kinga Krawiec
Ewelina Perdas
Agnieszka Wierzbowska
Wojciech Fendler

Frontiers in Oncology

doi 10.3389/fonc.2023.1250355

3,582 views
9 citations

Review

Published on 26 Sep 2023

Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?

in Hematologic Malignancies

Yan-Ying Li
Liu-Yun Zhang
Yun-Hui Xiang
Dan Li
Juan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1127407

7,034 views
14 citations

Original Research

Published on 25 Sep 2023

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential

in Hematologic Malignancies

Estevão Carlos Silva Barcelos
Chiara Rompietti
Francesco Maria Adamo
Erica Dorillo
Filomena De Falco
Beatrice Del Papa
Stefano Baldoni
Manuel Nogarotto
Angela Esposito
Silvia Capoccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1218989

4,625 views
9 citations

Review

Published on 22 Sep 2023

Updates in pathobiological aspects of anaplastic large cell lymphoma

in Hematologic Malignancies

Rui Wu
Megan S. Lim

Frontiers in Oncology

doi 10.3389/fonc.2023.1241532

7,444 views
11 citations

Original Research

Published on 20 Sep 2023

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients

in Hematologic Malignancies

Weiqin Yao
Haifei Yang
Hongying You
Jingjing Shang
Yingying Zhai
Zhi Yan
Shuang Yan
Xiaolan Shi
Ying Yao
Jing Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1266868

3,008 views
7 citations

Original Research

Published on 19 Sep 2023

Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma

in Hematologic Malignancies

Yan Zhuang
Chenyu Li
Hua Jiang
Lu Li
Yuanteng Zhang
Wei Yu
WeiJun Fu

Frontiers in Oncology

doi 10.3389/fonc.2023.1264422

5,632 views
2 citations

Original Research

Published on 18 Sep 2023

Evaluation of factors leading to poor outcomes for pediatric acute lymphoblastic leukemia in Mexico: a multi-institutional report of 2,116 patients

in Hematologic Malignancies

Daniel C. Moreira
Oscar González-Ramella
Maite Echavarría Valenzuela
Angela K. Carrillo
Lane Faughnan
Godwin Job
Yichen Chen
Cesar Villegas
Andrea Ellis Irigoyen
Rosario Barra Urbays

Frontiers in Oncology

doi 10.3389/fonc.2023.1255555

6,568 views
11 citations

Review

Published on 14 Sep 2023

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms

in Hematologic Malignancies

Mario Henrique M. Barros
Paula Daniela S. Alves

Frontiers in Oncology

doi 10.3389/fonc.2023.1240359

7,815 views
6 citations

Brief Research Report

Published on 13 Sep 2023

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia

in Hematologic Malignancies

Ansel Nalin
Qiuhong Zhao
Timothy Voorhees
David Bond
Yazeed Sawalha
Walter Hanel
Audrey Sigmund
Kaitlin Annunzio
Lapo Alinari
Robert Baiocchi

Frontiers in Oncology

doi 10.3389/fonc.2023.1264387

2,645 views
1 citation

Case Report

Published on 13 Sep 2023

Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation

in Hematologic Malignancies

María Noel Spangenberg
Sofía Grille
Camila Simoes
Mariana Brandes
Joaquín Garcia-Luna
Ana Inés Catalán
Sabrina Ranero
Matilde Boada
Andreína Brugnini
Natalia Trias

Frontiers in Oncology

doi 10.3389/fonc.2023.1248964

3,263 views
3 citations

Original Research

Published on 12 Sep 2023

Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione Umana

in Hematologic Malignancies

Carla Minoia
Simonetta Viviani
Erica Silvestris
Simone Palini
Francesca Parissone
Giuseppe De Palma
Anna Fedina
Gennaro Cormio
Attilio Guarini
Guido Gini

Frontiers in Oncology

doi 10.3389/fonc.2023.1252433

7,095 views
8 citations

Mini Review

Published on 11 Sep 2023

Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: state of the art and science

in Hematologic Malignancies

Senthil Velan Bhoopalan
Shruthi Suryaprakash
Akshay Sharma
Marcin W. Wlodarski

Frontiers in Oncology

doi 10.3389/fonc.2023.1236038

9,271 views
12 citations

Original Research

Published on 11 Sep 2023

Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib

in Hematologic Malignancies

Yurim Jeong
Se Been Kim
Chae-Eun Yang
Min Seo Yu
Wan-Su Choi
Youngwoo Jeon
Jung-Yeon Lim

Frontiers in Oncology

doi 10.3389/fonc.2023.1252658

4,529 views
6 citations

2,053 articles

articles

Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

Location, location, location: mapping the lymphoma tumor microenvironment using spatial transcriptomics

Editorial: Biological aspects of bone marrow failure

Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience

Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma

Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era

The interplay of FLT3 and CXCR4 in acute myeloid leukemia: an ongoing debate

Case Report: A recurrent case of ALK-ALCL after autologous transplantation was successfully treated with BV + a modified CHEP chemotherapy containing mitoxantrone hydrochloride liposome with the addition of chidamide maintenance therapy

Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling

Biological insights into the role of TET2 in T cell lymphomas

Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report

High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation

Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential

Updates in pathobiological aspects of anaplastic large cell lymphoma

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients

Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma

Evaluation of factors leading to poor outcomes for pediatric acute lymphoblastic leukemia in Mexico: a multi-institutional report of 2,116 patients

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia

Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation

Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione Umana

Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: state of the art and science

Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib